Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models.
Ontology highlight
ABSTRACT: Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to find potential drug targets. The present study aims to investigate the applicability of gene knockout strategies to be used as the finding of drug targets using GSMMs. We performed single-gene knockout studies on existing GSMMs of the NCI-60 cell-lines obtained from 9 tissue types. The metabolic genes responsible for the growth of cancerous cells were identified and then ranked based on their cellular growth reduction. The possible growth reduction mechanisms, which matches with the gene knockout results
SUBMITTER: Paul A
PROVIDER: S-EPMC7794450 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA